Skip to main content
padlock icon - secure page this page is secure

Hormonal Contraceptive Exposure and Risk Factors for Meningioma in Soetomo Hospital 2012–2016

Buy Article:

$106.64 + tax (Refund Policy)

Background: Indonesia is the 5th most populated country implementing Family Planning with 3-monthly-injection of DMPA as the most widely used contraceptive method. Hormonal contraceptive has been related to risk for meningioma, a primary brain tumor occurred 2–3 times higher in female than male. This study aimed to investigate the incidence of meningioma in relation to hormonal contraceptive exposure in Indonesia. Method: This was a case-control study in Soetomo Hospital. All female patients with meningioma were confirmed by pathologic anatomy result; patients in the control group were confirmed with non-meningioma by head CT-scan. Results: Out of 212 cases, 184 patients (87%) used hormonal contraceptive, 13 patients used non-hormonal contraceptive IUD (6%), 15 patients (7%) used no method. Progestin-only (P) were used in 151 cases (86%), while combined-hormonal-contraceptive (Estrogen+Progestin) were used by 25 patients (14%). Three-monthly-injection of DMPA was the most common hormonal contraceptive used in 155 patients (73.1%), in which 63 patients (34.7%) used DMPA with duration of ≥15 years, 54 patients (31.2%) used 10–<15 years, 37 patients (22.9%) used 5–<10 years, 11 patients used 1–<5 years (7.6%), and <1 year in 6 patients (3.5%). Conclusion: Hormonal contraceptive was significantly increased the risk for meningioma (OR 2.19 (CI 95%; 1.32–3.62)), the risk for meningioma was the highest among 3 monthly-injection of DMPA acceptors (OR 3.13 (CI 95%; 2.03– 4.85)), and the longer duration of exposure to DMPA will increase the risk for meningioma, with the highest risk in duration of 10–<15 years (OR 2.33 (CI 95%; 1.31–4.15)) and ≥15 years (OR 4.45 (CI 95%; 2.35–8.35)).
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: DMPA; Exposure; Hormonal Contraceptive; Meningioma; Soetomo Hospital

Document Type: Research Article

Affiliations: 1: Staff of Fertility Endocrinology Reproductive, Department of Obstetric and Gynecology Soetomo Hospital – Faculty of Medicine, Airlangga University Surabaya, 60286, Indonesia 2: Staff of Social Obstetric Gynecology, Department of Obstetric and Gynecology Soetomo Hospital – Faculty of Medicine, Airlangga University Surabaya, 60286, Indonesia 3: Department of Obstetric and Gynecology Soetomo Hospital – Faculty of Medicine, Airlangga University Surabaya, 60286, Indonesia 4: Staff of Neurosurgeon Department Soetomo Hospital – Faculty of Medicine, Airlangga University Surabaya, 60286, Indonesia

Publication date: April 1, 2017

More about this publication?
  • ADVANCED SCIENCE LETTERS is an international peer-reviewed journal with a very wide-ranging coverage, consolidates research activities in all areas of (1) Physical Sciences, (2) Biological Sciences, (3) Mathematical Sciences, (4) Engineering, (5) Computer and Information Sciences, and (6) Geosciences to publish original short communications, full research papers and timely brief (mini) reviews with authors photo and biography encompassing the basic and applied research and current developments in educational aspects of these scientific areas.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more